MeSH term
Frequency | Condition_Probility | Animals | 22 | 0.0 |
Chromatography, High Pressure Liquid | 4 | 0.0 |
Male | 10 | 0.0 |
Radioimmunoassay | 3 | 0.0 |
Research Support, Non-U.S. Gov't | 23 | 0.0 |
Humans | 28 | 0.0 |
Dose-Response Relationship, Drug | 3 | 0.0 |
Rats | 11 | 0.0 |
Rats, Wistar | 3 | 0.0 |
Time Factors | 3 | 0.0 |
Amino Acid Sequence | 12 | 0.0 |
Cell Line | 2 | 0.0 |
Ligands | 4 | 0.0 |
Mice | 6 | 0.0 |
Molecular Sequence Data | 12 | 0.0 |
Neuropeptides/metabolism | 4 | 7.0 |
Research Support, U.S. Gov't, P.H.S. | 2 | 0.0 |
Sequence Alignment | 2 | 0.0 |
Autoradiography | 3 | 0.0 |
Binding, Competitive | 4 | 0.0 |
CHO Cells | 8 | 0.0 |
Cells, Cultured | 3 | 0.0 |
Comparative Study | 4 | 0.0 |
Hamsters | 8 | 0.0 |
Rats, Sprague-Dawley | 5 | 0.0 |
Structure-Activity Relationship | 2 | 0.0 |
Transfection | 5 | 0.0 |
Sequence Homology, Amino Acid | 4 | 0.0 |
Calcium/metabolism | 3 | 0.0 |
Cloning, Molecular | 3 | 0.0 |
Cyclic AMP/metabolism | 2 | 0.0 |
Guanosine 5'-O-(3-Thiotriphosphate)/metabolism | 3 | 3.0 |
Oligopeptides/*metabolism | 3 | 9.0 |
RNA, Messenger/analysis/genetics | 2 | 0.0 |
Thermodynamics | 2 | 0.0 |
Binding Sites | 3 | 0.0 |
Protein Binding | 3 | 0.0 |
Base Sequence | 3 | 0.0 |
Neuropeptides/*metabolism | 2 | 2.0 |
Adult | 3 | 0.0 |
Aged | 2 | 0.0 |
Female | 5 | 0.0 |
Middle Aged | 3 | 0.0 |
Oligopeptides/*blood | 2 | 40.0 |
Cattle | 2 | 0.0 |
Oligopeptides/biosynthesis/*genetics | 2 | 100.0 |
Sensitivity and Specificity | 2 | 0.0 |
Arginine/*analogs & derivatives/*pharmacology | 2 | 66.0 |
Neuropeptides/*pharmacology | 2 | 3.0 |
Sequence Analysis, DNA | 2 | 0.0 |
Radioligand Assay | 3 | 0.0 |
Tumor Cells, Cultured | 2 | 0.0 |
COS Cells | 2 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 2 | 0.0 |
